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A B S T R A C T
Background: HUTT test is used in evaluation of syncope. Isoprenaline and isosorbide dinitrate are used to
increase the sensitivity of the test. These drugs act by different mechanisms. We aimed to compare the
results of isoprenaline with isosorbide dinitrate.
Methods and results: We studied 198 subjects referred for HUTT to our institute; those above the age of
35 years were not included in our study, because isoprenaline was not used commonly above this age;
thus, only 90 subjects were analyzed.
We found that isosorbide dinitrate resulted in more HUTT-positive results than isoprenaline by
absolute risk difference of 26%; relative risk for positive isoprenaline was 60%, conﬁdence interval 0.38–
0.93, and P value of 0.03. There was no difference in frequency of types of responses, i.e. Type 1, Type 2,
and Type 3 between passive testing, isosorbide dinitrate, and isoprenaline, conﬁdence interval 1.53–
2.02, and P value 0.71. Time to get positive response was highest for passive testing followed by ISO and
ISDN; the mean was 16.85  7.00 min, 9.85  5.84 min, and 7.00  3.35 min, respectively. Statistically,
ISDN versus ISO time to get positive response was not signiﬁcant; P value was 0.074 and 95% conﬁdence
interval was 0.28 to 5.98.
Conclusions: Isosorbide dinitrate yields more positive HUTT than isoprenaline. The frequencies of type of
responses are not different between passive testing, isosorbide dinitrate, and isoprenaline. There is no
difference in time taken for positive response between isosorbide dinitrate and isoprenaline. In
comparison to isosorbide dinitrate and isoprenaline, passive testing showed longest time for positive
response.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Syncope is deﬁned in European Guidelines for the diagnosis and
management of syncope (version 2009) as transient loss of
conciseness (T-LOC) due to transient global cerebral hypoperfusion
characterized by rapid onset, short duration, and spontaneous
complete recovery.1
Vasovagal syncope (VVS) is one of the commonest types of
syncope. In a study published in NEJM, vasovagal was present in
(21.2%), cardiac in (9.5%), and orthostatic in (9.4%); for 36.6%, the
cause was unknown.2 Diagnosis of vasovagal syncope is sometimes
challenging. VVS is associated with hypotension and bradycardia.
The exact mechanism of VVS is still an enigma. Postulated
mechanisms state that, following prolonged standing, there is§ This study was done in Sri Jayadeva Institute of Cardiovascular Sciences and
Research, Cardiology, B.G. Road, Bangalore 560069, Karnataka, India.
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creativecommons.org/licenses/by-nc-nd/4.0/).pooling of blood in lower part of the body leading to central
hypovolumia; this leads to stimulation of baroreceptors in
carotids, and increasing the sympathetic stimulation, heart is
made to contract vigorously. This vigorous contraction stimulates
mechanoreceptors, paradoxically leading to withdrawal of sym-
pathetic drive and increasing parasympathetic output; this leads to
hypotension and bradycardia, respectively, leading to syncope.3
Head-up tilt test (HUTT) is used for diagnosis of syncope. This
test consists of brief periods of 5–20 min supine phase followed by
a passive tilt phase 20–40 min at 50–708. If the patient does not
develop symptoms during passive tilt, various techniques are used
to potentiate the test. These techniques are as follows: adminis-
tering drugs like isoprenaline (ISO), nitroglycerine (NTG), iso-
sorbide dinitrate (ISDN), or adenosine, or resorting to
nonpharmacological techniques like applying suction to lower
part of the body.
In HUTT, ISO and ISDN are commonly employed to potentiate
the test results. These two agents act by different mechanisms.
ISO increases sympathetic stimulation leading to increased
chronotrope, and inotropy on heart mimicking increaseds nitroglycerine in head-up tilt test, Indian Heart J. (2016), http://
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venodilator increases the pooling of blood in venous system thus
causing central hypovolumia seen in VVS.4
2. Aims and objectives
1. We aimed to ﬁnd out whether there is any difference between
ISDN versus ISO in terms of getting a positive versus a negative
test.
2. As mechanisms of action of ISO and ISDN are different, we aimed
to ﬁnd out whether the frequency of types of responses, see
Table 1, produced by passive testing, ISO, and ISDN are similar or
dissimilar.
Procedure time of HUTT is long; so, we aimed to ﬁnd out
between ISO and ISDN which consumes lesser time to get positive
results. We also compared time taken by passive testing versus
both drugs.
3. Methodology
This was a retrospective study. From the year 2009 to 2011,
patients referred to HUTT at our institute were analyzed for this
study. Totally, we found 198 subjects with age range from 5 to
84 years, but only subjects lesser than 35 years were included in
the study, because above the age of 35 years ISDN was used more
commonly as compared to ISO. So, we did not include them
initially in our study. Hence, the number of subjects included in
this study was 90. But for the purpose of increasing the power of
study, we did few statistical tests in all 198 subjects. However,
conclusions are only drawn from the subjects who are less than
35 years.
The data were collected from these 90 subjects, who had
undergone tilt procedure, and the protocol of tilt has been
described below. Following this, we have compared the sensitivity
of ISO and ISDN in the evaluation of syncope in terms of the
following: (1) positive versus a negative test, (2) frequency of types
of responses by passive testing, ISO, and ISDN, and (3) time taken
by passive testing versus both drugs.
3.1. Tilt protocol
Patients were tested in the morning with overnight fast. The
test was performed in a quiet room with dim light. Resuscitation
equipment with trained nurse and resident doctor was always
present while performing the test. The manual sphygmomanome-
ter BP recording was used for recording blood pressure once in
every 2 min, from the beginning to end of the test. ECG was
monitored continuously from beginning to end of test. IV canula
was placed with normal saline on ﬂow. Patients were advised to lay
supine for 20 min; following this, passive tilt at 708 was done for
20 min. In those who did not develop presyncope or syncope
during passive tilt, intravenous ISO (1–3 mg/min) for 20 min orTable 1
Classiﬁcation of HUTT-positive response.5
Type 1
Mixed
Heart rate falls at the time of syncope but the ventricular ra
for less than 10 s with or without asystole of less than 3 s. B
Type 2
Cardioinhibitory
(A) Cardioinhibition without asystole. Heart rate falls to a v
than 3 s does not occur. Blood pressure falls before the hear
(B) Cardioinhibition with asystole. Asystole occurs for more
Type 3
Vasodepressor
Heart rate does not fall more than 10% from its peak at the 
Exception 1. Chronotropic incompetence. No heart rate rise 
Exception 2. Excessive heart rate rise. An excessive heart rat
before syncope (i.e. greater than 130 beats min1).
Please cite this article in press as: Bilagi UR, et al. Isoprenaline versu
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20 min was given.
The test was concluded as positive if the patient along with
presyncope or syncope developed fall in systolic BP more than 25%
or/and drop in heart rate more than 30 beats min1. The patient
was then brought back to supine position immediately. Positive
test results were grouped into three types: Type 1 means a partial
decrease in heart rate and fall in BP. Type 2 means a decrease in
heart rate and fall in BP. Type 3, also called vasodepressor syncope,
consisted of fall in BP but without a decrease in heart rate.5
(See Table 1.)
Once the relevant data were collected, it was subjected to
appropriate statistical analysis, which has been described below.
3.2. Data analysis
SPSS version 17 was used to analyze data; G-Power was used to
assess the power of our sample. To prevent Type 1 error, alpha
value (P value) was set to less than 0.05. We tried to prevent type
2 errors by setting beta value at 0.80, but our post hoc power was
not achieved in some tests, and they are reported in appropriate
places.
Categorical variables were analyzed by contingency table,
relative risk, absolute risk difference, number needed to treat, and
chi-square tests. Means were expressed as mean  standard
deviations. Numerical variables were analyzed by nonparametric
Mann–Whitney test if the P value of normality of distribution by
Shapiro–Wilk was signiﬁcant, i.e. less than 0.05. If Shapiro–Wilk test
showed the P value not less than 0.05, then independent t test was
performed. Levene’s test for equality of variances was considered
while reporting independent t test results from SPSS output. Effect
sizes were reported by r square value, considered small for 0.01,
medium for 0.9, and large if 0.25.
4. Results
4.1. Baseline characteristics of our sample
A total of 90 subjects were included in this study. The age range
was from 5 years to 35 years. Mean age was 17.97  7.27 years.
Passive testing, ISO, and ISDN respectively, had a mean of
19  7.41 years, 16.86  7.19 years, and 19.62  7.29 years, and
numbers of subjects in each of these groups were 13, 51, and 26,
respectively. Age-wise skewness of the whole sample was 0.67, and
for ISO group, ISDN, and passive testing group they were 0.8, 0.6, and
0.3, respectively. Mann–Whitney test was performed to check for
signiﬁcant difference between ISO and ISDN group with respect to
age, and it was found to be not signiﬁcant (two-tailed P value was
0.91).
Further, out of 90 subjects, there were 46 males and 44 females.
Age versus sex comparison by Mann–Whitney test showed no
signiﬁcant difference, i.e. two-tailed P value was 0.27. So at
baseline, groups were comparable with respect to age, sex, and
drug used. (See Table 2 and refer Supplementary Appendix 1.)te does not fall to less than 40 beats min1 or falls to less than 40 beats min1
lood pressure falls before the heart rate falls.
entricular rate less than 40 beats min1 for more than 10 s but asystole of more
t rate falls.
 than 3 s. Blood pressure falls with or occurs before the heart rate fall.
time of syncope.
during the tilt testing (i.e. less than 10% from the pre-tilt rate).
e rise both at the onset of the upright position and throughout its duration
s nitroglycerine in head-up tilt test, Indian Heart J. (2016), http://
Table 2
Baseline comparison of age, sex, and drug used in HUTT.
Parameter Total number
of subjects (N)
Mean (age) Median (age) Std. deviation
(age)
Minimum (age) Maximum (age) Skewness P value by
Mann–
Whitney test
Power for
Mann–
Whitney test
Sex
Female 44 17 15 6.74 8 34 1.01 0.27 0.22
Male 46 18.89 18 7.72 5 33 0.40
Total 90 17.97 16 7.28 5 34 0.67
Drug used
Passive testing 13 19 20 7.41 10 31 0.32 0.91 0.33
ISO 51 16.86 15 7.17 5 34 0.87
ISDN 26 19.62 17.5 7.28 11 34 0.61
Total 90 17.97 16 7.28 5 34 0.67
Table 4
Time to positive response with respect to passive testing, ISO, and ISDN in minutes.
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negative, one subject had postural orthostatic tachycardia, and one
more had Pseudo syncope. Remaining 59 had Type 1 (24 subjects),
Type 2 (12 subjects), and Type 3 (13 subjects) response.
4.2. Comparison of sensitivity of ISO versus ISDN for HUTT positivity
77 subjects were subjected to either ISO or ISDN. Of 26 subjects
of ISDN group, 9 had syncope or presyncope, and in ISO group of
51 subjects, only 20 had syncope and presyncope included in Type
1 or Type 2 or Type 3 responses. The relative risk of positive ISO was
60%, with conﬁdence interval of 0.39–0.93; Fisher’s exact test P
value was 0.03 and Pearson chi-square test P value was 0.03, and
both were signiﬁcant (but P value by continuity correction was not,
i.e. 0.05). Suggesting the use of ISDN leads to higher positive results
compared to ISO. The absolute risk difference was 26%, suggesting
26% increase chance of getting positive HUTT with ISDN as
compared to ISO; the number needed to treat was 3.82. Speciﬁcity
and sensitivity of these agents is not mentioned because there is no
gold standard test for diagnosing vasovagal syncope. Refer
Supplementary Appendix 2 for further details.
4.3. Comparison of frequency of type of responses with respect to
passive testing, ISO, and ISDN
49 subjects were HUTT positive, i.e. Type 1, Type 2, or Type
3 responses. Conﬁdence interval was 1.53–2.02. Chi-square test
was performed and it showed no signiﬁcant difference in
frequency of types of HUTT positive with respect to passive
testing, ISO, and ISDN, i.e. Fisher’s exact test P value was 0.71 and
x2 test goodness of ﬁt for the contingency table post hoc Power
achieved was 0.82. Refer Supplementary Appendix 3.
4.4. Comparison of time to positive response with respect to ISDN, ISO,
and passive testing
Time to response in 49 HUTT-positive patients was studied.
Passive testing signiﬁcantly took more time to produce a positive
test as compared to ISDN and ISO. This was tested by anTable 3
Cross-tabulation of type of response and drug used.
Response type Drug used Total
Passive testing ISO ISDN
Negative 0 30 9 39
Type 1 6 11 7 24
Type 2 4 3 5 12
Type 3 2 6 5 13
POT 0 1 0 1
Pseudosyncope 1 0 0 1
Total 13 51 26 90
Please cite this article in press as: Bilagi UR, et al. Isoprenaline versu
dx.doi.org/10.1016/j.ihj.2016.06.007independent t test; ISO versus passive test P value was 0.007;
95% conﬁdence limit was 1.96–11.34 and effect size by r square
was 0.009 (small effect). Independent t test for passive testing and
ISDN revealed the P value was 0.001; 95% conﬁdence interval was
4.85–14.15 and r square effect size was 0.08 (medium effect). See
Tables 4 and 5 and refer Supplementary Appendix 4.
There was no signiﬁcant difference between ISO and ISDN time
to response positive test. Independent t test showed P value as
0.074; 95% conﬁdence interval was 0.29 to 5.99; post hoc power
estimated using G power showed a value of 0.42. (Not sufﬁcient to
ﬁnd a difference, we need a bigger sample.) See Tables 4 and 5 and
refer Supplementary Appendix 4.
5. Discussion
Utility of HUTT has been questioned in recent years; however, it
has a profound value in VVS and also in variety of other
conditions.6 In a study by Udani et al., of the HUTT-positive
sixteen children, seven were on long-term antiepileptic drugs, but
only two had epileptiform abnormalities on their electroencepha-
logram (EEG).7
Apart from this, HUTT utility is also extendable to patients with
cardiac syncope, i.e. HOCM,8 aortic stenosis, and sick sinus
syndrome, because syncope in these cases may also be associated
with autonomic dysfunction.9
In carotid hypersensitivity subjects with syncope, pacing in
HUTT-negative subjects resulted in greater clinical beneﬁt than in
subjects with HUTT-positive subjects.10,11 Thus, HUTT has its
utility in syncope apart from VVS and this makes the test still a
valid one.
Current study results have shown that ISDN has a 26% increased
chance of getting positive HUTT as compared to ISO. Similar
ﬁndings were observed in a meta-analysis conducted by Forleo
et al.12Drug used N Minimum Maximum Mean Std. deviation
Passive testing 12 5 27 16.50 7.00
ISO 20 1 20 9.85 5.84
ISDN 17 2 15 7.00 3.35
Table 5
Time to positive response.
Comparison P value 95% conﬁdence
interval
Effect
size, r
Power
Passive testing versus ISDN 0.001 4.85–14.35 0.08
Passive testing versus ISO 0.007 1.96–11.34 0.009
ISDN versus ISO 0.074 0.29 to 5.99 0.42
s nitroglycerine in head-up tilt test, Indian Heart J. (2016), http://
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between the different modalities of HUTT. Although ISO is a
sympathomimetic drug, ISDN is a venodilator (both have different
mechanisms of precipitation of syncope). Our study did not show
any difference in frequency of types of responses, i.e. Type 1
(mixed), Type 2 (cardioinhibitory), and Type 3 (vasodepressor)
across passive testing, ISDN, and ISO.
We also compared the time to get a positive response between
passive testing, ISDN, and ISO. It was found that ISDN had the
lowest mean (7.00  3.35 min), followed by ISO (9.85  5.84 min);
longest time to get positive response was with passive testing
(16.50  7.00 min). The difference between passive testing compared
to ISDN, and passive testing compared to ISO was statistically
signiﬁcant. But, ISDN compared to ISO was statistically not signiﬁcant
see Table 5.
Post hoc power analysis of our study showed a power of 0.44;
this means, our sample size was not adequate to ﬁnd difference
between ISDN and ISO. To achieve a power of 0.8, we needed in
each group 47 subjects and totally 94 subjects; but our sample was
20 and 17 for ISO and ISDN, respectively. In a study by Zeng et al.,
they found signiﬁcant less duration of test time for ISDN as
compared to ISO, i.e. 24.84  35.15 versus 35.7  6.28 min
[P < 0.01].13 We had excluded the patients above the age of 35 years
in the current study, because ISO was less used above the age of
35 years. Our sample size was reduced by excluding those subjects,
and so as to recheck the hypothesis, we did nonparametric test on all
198 subjects. This showed the signiﬁcant P value of 0.02 for difference
in time to positive response between ISDN and ISO. Refer
Supplementary Appendix 5. Our P value for 94 subjects was 0.07,
which is very much near to signiﬁcant P value, i.e., 0.05. This value of
0.07 means there is 93% chance that ISDN has lesser time to get
positive response as compared to ISO. Further, on taking the whole
sample of 198 subjects, signiﬁcant P value was achieved, which is
0.02. Apart from this, as mentioned above in a study, Zeng et al. have
found that ISDN has lesser time to positive response in comparison to
ISO. So, we believe that, if we had larger sample, we would have got
difference between ISO and ISDN time to positive response. Likewise,
there may be other unexplored factors that could have contributed for
this insigniﬁcant ﬁnding.
6. Limitation
The limitations of our study are the following. It was a
retrospective study. We could not include all patients who were
referred for HUTT because ISO was less used in people who were
above the age of 35 years, and so they were excluded from our
study; this lead to decrease in sample size and reducing the power
of our study.
7. Conclusion
Our study showed that the chances of getting positive HUTT by
ISDN is 26% more, as compared to ISO, in subjects who failed to
develop positive HUTT during passive testing. Although the
mechanism of production of syncope by ISO, ISDN, and passivePlease cite this article in press as: Bilagi UR, et al. Isoprenaline versu
dx.doi.org/10.1016/j.ihj.2016.06.007testing are different, our study showed no difference in incidence
of type of positive HUTT, i.e. mixed, cardioinhibitory, or
vasodepressor response. HUTT is a time-consuming process; time
spent to get a positive response by passive testing was highest and
statistically signiﬁcant compared to ISDN and ISO. Even though the
mean time for ISDN was lower in comparison to ISO, this ﬁnding
was not statistically signiﬁcant. This insigniﬁcant ﬁnding may be
due to the smaller sample size and other factors.
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